![](/img/cover-not-exists.png)
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma
Zinzani, P. L., Karlin, L., Radford, J., Caballero, D., Fields, P., Chamuleau, M. E. D., dAmore, F., Haioun, C., Thieblemont, C., Gonzalez-Barca, E., Garcia, C. G., Johnson, P. W., van Imhoff, G. W.,Volume:
101
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2016.146977
Date:
October, 2016
File:
PDF, 558 KB
english, 2016